Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumours worldwide. The mortality-to-incidence ratio is up to 91.6% in many countries, representing the third leading cause of cancer-related deaths. Systemic drugs, including the multikinase inhibitors sorafenib and lenvatinib, are f...

Descripción completa

Detalles Bibliográficos
Autores principales: Villarruel-Melquiades, Fernanda, Mendoza-Garrido, María Eugenia, García-Cuellar, Claudia M, Sánchez-Pérez, Yesennia, Pérez-Carreón, Julio Isael, Camacho, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198058/
https://www.ncbi.nlm.nih.gov/pubmed/37213397
http://dx.doi.org/10.3748/wjg.v29.i17.2571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198058/
https://www.ncbi.nlm.nih.gov/pubmed/37213397
http://dx.doi.org/10.3748/wjg.v29.i17.2571

Ejemplares similares